top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy

katie8288
Jun 23, 2022
0 min read

Recent Posts

uniQure Announces Plan BLA Submission for AMT-130 in Huntington's Disease

uniQure Announces Plan BLA Submission for AMT-130 in Huntington's Disease

A Mother's Race Against Time

A Mother's Race Against Time

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease

Comments

bottom of page